Compile Data Set for Download or QSAR
maximum 50k data
Found 242 with Last Name = 'pham' and Initial = 'j'
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554143(((S)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554141((1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554145(((R)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561222(CHEMBL4741942 | US11325938, Ex 5)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554147(((S)-1-((((2S,3S,4R,5R)-5-(6-chloro-4- (cyclopenty...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554149(((R)-1-((((2S,3S,4R,5R)-5-(6-chloro-4- (cyclopenty...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554150((2-((((2S,3S,4R,5R)-5-(6-chloro-4- (cyclopentylami...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554152(((R)-1-((((2S,3S,4R,5R)-5-(6-chloro-4- (cyclopenty...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554153(((1S,2S)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclope...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554154(((1R,2S)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclope...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561223(CHEMBL4753449 | US11325938, Ex 57)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554157((1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561230(CHEMBL4784951 | US11325938, Ex 194)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554159((((((2S,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamino...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554162(((((2R,3S,4R,5R)-5-(5-chloro-7- ((cyclopropylmethy...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554163(((((2R,3S,4R,5R)-5-(5-chloro-7-((3- chlorobenzyl)a...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554164(((((2R,3S,4R,5R)-5-(5-chloro-7- (cyclobutylamino)-...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554165(((((2R,3S,4R,5R)-5-(5-chloro-7- ((cyclobutylmethyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554166((((((2S,3S,4R,5R)-5-(5-chloro-7- ((cyclopropylmeth...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554167(((((2R,3S,4R,5R)-5-(5-chloro-7-((2- chlorobenzyl)a...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554168((((((2S,3S,4R,5R)-5-(5-chloro-7-((2- chlorobenzyl)...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561225(CHEMBL4781819 | US11325938, Ex 28)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554170((1-(((2R,3S,4R,5R)-5-(6-chloro-4- (methylamino)-1H...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554171((1-(((2R,3S,4R,5R)-5-(6-chloro-4- ((cyclopropylmet...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561224(CHEMBL4751244 | US11325938, Ex 31)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554173(((S)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554174(((R)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554176(((((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentylamino)...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554177((2-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554178((2-(((2R,3S,4R,5R)-5-(6-bromo-4- (cyclopentylamino...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554180((1-(((2R,3S,4R,5R)-5-(6-chloro-4-(((S)-2,3- dihydr...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554181((1-(((2S,4R,5R)-5-(6-chloro-4- (cyclopentylamino)-...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554183((1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554184((((((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamino...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554185((((((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamino...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561233(CHEMBL4788607 | US11325938, Ex 55)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561235(CHEMBL4791561 | US11325938, Ex 56)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561223(CHEMBL4753449 | US11325938, Ex 57)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554189((1-(((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554191((1-(((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554192((2-(((2R,3S,4R,5R)-5-(6-chloro-4-(((R)-2,3- dihydr...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561239(CHEMBL4796959 | US11325938, Ex 62)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561238(CHEMBL4752114 | US11325938, Ex 63)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554196(((S)-1-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554197(((S)-2-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554199((2-(((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554200((2-(((2R,3S,4R,5R)-5-(5-chloro-7- (cyclopentylamin...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554201((2-(((2R,3S,4R,5R)-5-(4-(cyclopentylamino)-6- (2-h...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM554202(((R)-2-(((2R,3S,4R,5R)-5-(6-chloro-4- (cyclopentyl...)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5'-nucleotidase(Homo sapiens (Human))
Oric Pharmaceuticals

US Patent
LigandPNGBDBM50561237(CHEMBL4743237 | US11325938, Ex 151)
Affinity DataIC50: <100nMAssay Description:Assay Reaction ConditionsAssay Volume: 70 μlReaction Volume: 50 μlCD73: 0.3208 nMAMP: 15 μMAssay Buffer: 25 mM Tris-HCL, pH 7.4, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 242 total ) | Next | Last >>
Jump to: